Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index; 12 of the 87 sources its claims cite were checked for support.

Six decades of preventing and treating childhood anxiety disorders: a systematic review and meta-analysis to inform policy and practice

Open access

Abstract

Question Anxiety disorders are the most prevalent childhood mental disorders. They also start early and persist, causing high individual and collective costs. To inform policy and practice, we therefore asked: What is the best available research evidence on preventing and treating these disorders? Methods We sought randomised controlled trials (RCTs) evaluating interventions addressing anxiety problems in young people. We identified RCTs by searching CINAHL, ERIC, MEDLINE, PsycINFO and Web of Science. Thirty-three RCTs met inclusion criteria—evaluating 8 prevention programmes, 12 psychosocial treatments and 7 pharmacological treatments. We then conducted meta-analyses by intervention type. Findings For prevention, the cognitive-behavioural therapy (CBT) programme Coping and Promoting Strength stood out for reducing anxiety diagnoses. For psychosocial treatment, 9 CBT interventions also reduced diagnoses: Cool Kids ; C ool Little Kids Plus Social Skills; Coping Cat; Coping Koala; One-Session Treatment; Parent Education Program; Skills for Academic and Social Success; Strongest Families and Timid to Tiger . Successful CBT interventions were used with children ranging from pre-schoolers to teens in homes, communities/schools and clinics. For pharmacological treatment, selective-serotonergic-reuptake-inhibitors (SSRIs) significantly improved symptoms. Fluoxetine stood out for also reducing post-test diagnoses, but caused adverse events. Meta-analyses indicated strongest effects for CBT (Log OR=0.95; 95% CI, 0.69 to 1.21) and SSRI treatments (1.57; 1.09 to 2.06). Conclusions CBT is effective for preventing and treating childhood anxiety—across a range of ages and formats. Fluoxetine is also an effective treatment but side effects must be managed. CBT prevention and treatment interventions should be made widely available, adding fluoxetine in severe cases.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found the strongest evidence for CBT in both preventing and treating childhood anxiety disorders, with fluoxetine also showing benefit for symptom improvement and some diagnostic reduction. The authors conclude that CBT prevention and treatment should be widely available, with fluoxetine considered for more severe cases and side effects monitored.

Key findings

  • The review included 33 RCTs: 8 prevention programmes, 12 psychosocial treatments, and 7 pharmacological treatments.
  • In meta-analysis, CBT treatment programmes significantly outperformed comparison conditions for reducing diagnoses (Log OR=0.95; 95% CI, 0.69 to 1.21), while CBT prevention programmes did not significantly outperform comparison conditions (Log OR=0.50; 95% CI, −0.14 to 1.13).
  • SSRIs significantly improved symptoms versus placebo (Log OR=1.57; 95% CI, 1.09 to 2.06); fluoxetine also reduced post-test diagnoses, but the paper notes adverse events.
  • Specific CBT interventions with diagnostic benefits included Coping and Promoting Strength for prevention, and 9 CBT treatment interventions including Cool Kids, Coping Cat, Coping Koala, One-Session Treatment, Parent Education Program, SASS, Strongest Families, and Timid to Tiger.

Methods

  • Systematic review and meta-analysis of randomised controlled trials evaluating interventions for anxiety problems in people aged 18 years or younger.
  • Searches covered CINAHL, ERIC, MEDLINE, PsycINFO, and Web of Science from January 1950 to May 2018, restricted to English-language articles and high-income countries.
  • Separate random-effects meta-analyses were conducted for CBT prevention, CBT treatment, and SSRIs; effect sizes were expressed as odds ratios and heterogeneity assessed with Cochran’s Q and Egger’s tests.

Limitations

  • The paper states that inclusion criteria differed for blinding between psychosocial and medication studies, which may introduce bias favouring psychosocial studies; it also notes different follow-up requirements for medication versus psychosocial studies.
  • The authors say their high thresholds for study inclusion likely excluded many interventions being implemented.
  • Evident from the text: the review was limited to English-language studies and high-income countries, so findings may not generalise to other settings (this is evident from the methods, not stated as a limitation in the paper).

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/ebmental-2019-300096

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Search process
Figure 1 Search processCC BY-NC · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 58 Not checked · 49 Own results and interpretations

33 more claims

Create a free account to see all 112 claims and to verify the 75 references still open.

See all claims — free account
  • It may state two separate claims as one. 63
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. 10.1037/0022-006x.67.1.145 · doi:10.1037/0022-006x.67.1.145 · Paper page

Cited by

See all 63

Metadata

Authors
Schwartz, C., Barican, J. L., Yung, D., Zheng, Y., & Waddell, C.
Affiliations
Simon Fraser University (CA)
Corresponding author
Waddell, Charlotte
Venue
Evidence-Based Mental Health
Publisher
BMJ
Published
2019-07-17
Volume
22
Issue
3
Pages
103-110
ISSN
  • 1362-0347 (ISSN-L)
  • 1468-960X
OpenAlex
W2961583591
Cited by
63
References
53
Citations by year
2026: 7 · 2025: 9 · 2024: 9 · 2023: 10 · 2022: 11 · 2021: 12 · 2020: 3 · 2019: 2
FWCI
1.11
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Evidence-Based Mental Health (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
  • Summit (Simon Fraser University) (submittedVersion)
Funders
British Columbia Ministry for Children and Family Development
Topics
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › Child Therapy and Development
Keywords
childhood anxiety disorders, anxiety prevention, cognitive behavioral therapy, psychosocial interventions, pharmacotherapy, selective serotonin reuptake inhibitors, fluoxetine, parent education, school-based intervention, adverse drug reactions, mental health policy
MeSH terms
Adolescent, Anxiety Disorders, Child, Fluoxetine, Humans, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Six decades of preventing and treating childhood anxiety disorders: a systematic review and meta-analysis to inform policy and practice. https://app.cochat.ai/papers/10.1136/ebmental-2019-300096
The paper
Schwartz, C., Barican, J. L., Yung, D., Zheng, Y., & Waddell, C. (2019). Six decades of preventing and treating childhood anxiety disorders: a systematic review and meta-analysis to inform policy and practice. Evidence-Based Mental Health. https://doi.org/10.1136/ebmental-2019-300096

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.